Literature DB >> 2007661

Biology of basal cell carcinoma (Part II).

S J Miller1.   

Abstract

Host-tumor relationships involve several factors that can enhance or suppress neoplastic growth. This second part of a review of basal cell carcinoma biology examines the role that hormones, cytokines, local and systemic immunity, congenital and genetic syndromes, and environmental factors play in the development of this neoplasm. Theories of etiology and pathogenesis are discussed, and transplantation and cell culture techniques used to study this cancer are explored. Valuable second-line therapies for treatment of multiple tumors are reviewed, and important areas of present and future research are emphasized.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2007661     DOI: 10.1016/0190-9622(91)70022-t

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  14 in total

1.  Analysis of 1,25-dihydroxyvitamin D(3) receptors (VDR) in basal cell carcinomas.

Authors:  J Reichrath; J Kamradt; X H Zhu; X F Kong; W Tilgen; M F Holick
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

2.  Long-noncoding RNAs in basal cell carcinoma.

Authors:  Michael Sand; Falk G Bechara; Daniel Sand; Thilo Gambichler; Stephan A Hahn; Michael Bromba; Eggert Stockfleth; Schapoor Hessam
Journal:  Tumour Biol       Date:  2016-02-09

3.  Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers.

Authors:  A Ziegler; D J Leffell; S Kunala; H W Sharma; M Gailani; J A Simon; A J Halperin; H P Baden; P E Shapiro; A E Bale
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

4.  Vismodegib (erivedge) for advanced Basal cell carcinoma.

Authors:  Chris Fellner
Journal:  P T       Date:  2012-12

5.  Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin.

Authors:  R Poulsom; A M Hanby; M Pignatelli; R E Jeffery; J M Longcroft; L Rogers; G W Stamp
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

6.  Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER).

Authors:  Eun-Ae Cho; Fergal J Moloney; Hong Cai; Annie Au-Yeung; Carlos China; Richard A Scolyer; Benafsha Yosufi; Mark J Raftery; Jason Z Deng; Stephen W Morton; Paula T Hammond; Hendrik-Tobias Arkenau; Diona L Damian; Douglas J Francis; Colin N Chesterman; Ross St C Barnetson; Gary M Halliday; Levon M Khachigian
Journal:  Lancet       Date:  2013-05-07       Impact factor: 79.321

7.  Association study indicates combined effect of interleukin-10 and angiotensin-converting enzyme in basal cell carcinoma development.

Authors:  Nikolaos Koronellos; Christos Yapijakis; Alexandros Katoulis; Dimitris Avgoustidis; Antonis Vylliotis; Veronica Papakosta; Stavroula Diamantopoulou; Omiros Zografos; Georgia Vairaktari; Eleftherios Vairaktaris; Stavros Vassiliou
Journal:  Arch Dermatol Res       Date:  2020-08-08       Impact factor: 3.017

8.  Notch signalling is linked to epidermal cell differentiation level in basal cell carcinoma, psoriasis and wound healing.

Authors:  Jacques Thélu; Patricia Rossio; Bertrand Favier
Journal:  BMC Dermatol       Date:  2002-04-29

9.  Loss of heterozygosity analysis of keratoacanthoma reveals multiple differences from cutaneous squamous cell carcinoma.

Authors:  A J Waring; M Takata; I Rehman; J L Rees
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

10.  Differential patterns of placental and epithelial cadherin expression in basal cell carcinoma and in the epidermis overlying tumours.

Authors:  A Pizarro; C Gamallo; N Benito; J Palacios; M Quintanilla; A Cano; F Contreras
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.